Mối liên hệ giữa HLA-B27 với bệnh viêm cột sống dính khớp và các đặc điểm lâm sàng của bệnh viêm cột sống dính khớp liên quan đến HLA-B27: Một phân tích tổng hợp

Braun J, Sieper J (2007) Ankylosing spondylitis. Lancet 369:1379–1390 Dougados M, Baeten D (2011) Spondyloarthritis. Lancet 377:2127–2137 Gao X, Wendling D, Botteman MF, Carter JA, Rao S et al (2012) Clinical and economic burden of extra-articular manifestations in ankylosing spondylitis patients treated with anti-tumor necrosis factor agents. J Med Econ 15:1054–1063 Jang JH, Ward MM, Rucker AN, Reveille JD, Davis JC Jr et al (2011) Ankylosing spondylitis: patterns of radiographic involvement—a re-examination of accepted principles in a cohort of 769 patients. Radiology 258:192–198 Braun J, van den Berg R, Baraliakos X, Boehm H, Burgos-Vargas R et al (2011) 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 70:896–904 Jeong H, Eun YH, Kim IY, Kim H, Ahn JK et al (2016) Drug survival of tumor necrosis factor alpha inhibitors in patients with ankylosing spondylitis in Korea. Korean J Intern Med. doi:10.3904/kjim.2016.042 Liu J, Dong Z, Zhu Q, He D, Ma Y et al (2016) TNF-alpha promoter polymorphisms predict the response to etanercept more powerfully than that to infliximab/adalimumab in spondyloarthritis. Sci Rep 6:32202 Cavazzana I, Taraborelli M, Fredi M, Tincani A, Franceschini F (2014) Aseptic meningitis occurring during anti-TNF-alpha therapy in rheumatoid arthritis and ankylosing spondylitis. Clin Exp Rheumatol 32:732–734 Zavada J, Uher M, Sisol K, Forejtova S, Jarosova K et al (2016) A tailored approach to reduce dose of anti-TNF drugs may be equally effective, but substantially less costly than standard dosing in patients with ankylosing spondylitis over 1 year: a propensity score-matched cohort study. Ann Rheum Dis 75:96–102 Nossent JC, Sagen-Johnsen S, Bakland G (2014) Tumor necrosis factor-alpha promoter-308/238 polymorphism association with less severe disease in ankylosing spondylitis is unrelated to serum TNF-alpha and does not predict TNF inhibitor response. J Rheumatol 41:1675–1682 Bowness P (2015) Hla-B27. Annu Rev Immunol 33:29–48 Kim K, Bang SY, Lee S, Lee HS, Shim SC et al (2015) An HLA-C amino acid variant in addition to HLA-B*27 confers risk for ankylosing spondylitis in the Korean population. Arthritis Res Ther 17:342 Al-Qadi R, Salih SF, AlDoski HJ, Nabeel M, Ali JH et al (2015) Association of HLA-B*27 with ankylosing spondylitis in Kurdish patients. Int J Rheum Dis. doi:10.1111/1756-185X.12605 Akassou A, Yacoubi H, Jamil A, Dakka N, Amzazi S et al (2015) Prevalence of HLA-B27 in Moroccan healthy subjects and patients with ankylosing spondylitis and mapping construction of several factors influencing AS diagnosis by using multiple correspondence analysis. Rheumatol Int 35:1889–1894 Diyarbakir E, Eyerci N, Melikoglu M, Topcu A, Pirim I (2012) HLA B27 subtype distribution among patients with ankylosing spondylitis in eastern Turkey. Genet Test Mol Biomark 16:456–458 Qi J, Li Q, Lin Z, Liao Z, Wei Q et al (2013) Higher risk of uveitis and dactylitis and older age of onset among ankylosing spondylitis patients with HLA-B*2705 than patients with HLA-B*2704 in the Chinese population. Tissue Antigens 82:380–386 Yi L, Wang J, Guo X, Espitia MG, Chen E et al (2013) Profiling of hla-B alleles for association studies with ankylosing spondylitis in the chinese population. Open Rheumatol J 7:51–54 Li H, Li Q, Ji C, Gu J (2016) Ankylosing spondylitis patients with HLA-B*2704 have More uveitis than patients with HLA-B*2705 in a North Chinese population. Ocul Immunol Inflamm 1–5: doi:10.1080/09273948.2016.1188967 Diaz-Pena R, Vidal-Castineira JR, Lopez-Vazquez A, Lopez-Larrea C (2016) HLA-B*40:01 is associated with ankylosing spondylitis in HLA-B27-positive populations. J Rheumatol 43:1255–1256 Wei JC, Sung-Ching HW, Hsu YW, Wen YF, Wang WC et al (2015) Interaction between HLA-B60 and HLA-B27 as a better predictor of ankylosing spondylitis in a Taiwanese population. PLoS ONE 10:e0137189 Videm V, Cortes A, Thomas R, Brown MA (2014) Current smoking is associated with incident ankylosing spondylitis—the HUNT population-based Norwegian health study. J Rheumatol 41:2041–2048 van Gaalen FA, Verduijn W, Roelen DL, Bohringer S, Huizinga TW et al (2013) Epistasis between two HLA antigens defines a subset of individuals at a very high risk for ankylosing spondylitis. Ann Rheum Dis 72:974–978 Acar M, Cora T, Tunc R, Acar H (2012) HLA-B27 subtypes in Turkish patients with ankylosing spondylitis and healthy controls. Rheumatol Int 32:3103–3105 al Attia HM, Sherif AM, Hossain MM, Ahmed YH (1998) The demographic and clinical spectrum of Arab versus Asian patients with ankylosing spondylitis in the UAE. Rheumatol Int 17:193–196 Liu Y, Jiang L, Cai Q, Danoy P, Barnardo MC et al (2010) Predominant association of HLA-B*2704 with ankylosing spondylitis in Chinese Han patients. Tissue Antigens 75:61–64 Mou Y, Wu Z, Gu J, Liao Z, Lin Z et al (2010) HLA-B27 polymorphism in patients with juvenile and adult-onset ankylosing spondylitis in Southern China. Tissue Antigens 75:56–60 Harfouch EI, Al-Cheikh SA (2011) HLA-B27 and its subtypes in Syrian patients with ankylosing spondylitis. Saudi Med J 32:364–368 Cipriani A, Rivera S, Hassanhi M, Marquez G, Hernandez R et al (2003) HLA-B27 subtypes determination in patients with ankylosing spondylitis from Zulia, Venezuela. Hum Immunol 64:745–749 Kchir MM, Hamdi W, Laadhar L, Kochbati S, Kaffel D et al (2010) HLA-B, DR and DQ antigens polymorphism in Tunisian patients with ankylosing spondylitis (a case-control study). Rheumatol Int 30:933–939 Chavan H, Samant R, Deshpande A, Mankeshwar R (2011) Correlation of HLA B27 subtypes with clinical features of ankylosing spondylitis. Int J Rheum Dis 14:369–374 Pazar B, Safrany E, Gergely P, Szanto S, Szekanecz Z et al (2010) Association of ARTS1 gene polymorphisms with ankylosing spondylitis in the Hungarian population: the rs27044 variant is associated with HLA-B*2705 subtype in Hungarian patients with ankylosing spondylitis. J Rheumatol 37:379–384 Ben Radhia K, Ayed-Jendoubi S, Sfar I, Ben Romdhane T, Makhlouf M et al (2008) Distribution of HLA-B*27 subtypes in Tunisians and their association with ankylosing spondylitis. Joint Bone Spine 75:172–175 Liu X, Hu LH, Li YR, Chen FH, Ning Y et al (2010) The association of HLA-B*27 subtypes with ankylosing spondylitis in Wuhan population of China. Rheumatol Int 30:587–590 Alaez C, Gazit E, Ibarrola B, Yaron M, Livneh A et al (2007) Distribution of HLA-B27 subtypes in ankylosing spondylitis in an Israeli population. Arch Med Res 38:452–455 Birinci A, Bilgici A, Kuru O, Durupinar B (2006) HLA-B27 polymorphism in Turkish patients with ankylosing spondylitis. Rheumatol Int 26:285–287 Gonzalez S, Garcia-Fernandez S, Martinez-Borra J, Blanco-Gelaz MA, Rodrigo L et al (2002) High variability of HLA-B27 alleles in ankylosing spondylitis and related spondyloarthropathies in the population of northern Spain. Hum Immunol 63:673–676 Lopez-Larrea C, Blanco-Gelaz MA, Torre-Alonso JC, Bruges Armas J, Suarez-Alvarez B et al (2006) Contribution of KIR3DL1/3DS1 to ankylosing spondylitis in human leukocyte antigen-B27 Caucasian populations. Arthritis Res Ther 8:R101 Varnavidou-Nicolaidou A, Karpasitou K, Georgiou D, Stylianou G, Kokkofitou A et al (2004) HLA-B27 in the Greek Cypriot population: distribution of subtypes in patients with ankylosing spondylitis and other HLA-B27-related diseases. The possible protective role of B*2707. Hum Immunol 65:1451–1454 Lopez-Larrea C, Gonzalez-Roces S, Pena M, Dominguez O, Coto E et al (1995) Characterization of B27 haplotypes by oligotyping and genomic sequencing in the Mexican Mestizo population with ankylosing spondylitis: juvenile and adult onset. Hum Immunol 43:174–180 Gonzalez-Roces S, Alvarez MV, Gonzalez S, Dieye A, Makni H et al (1997) HLA-B27 polymorphism and worldwide susceptibility to ankylosing spondylitis. Tissue Antigens 49:116–123 Ren EC, Koh WH, Sim D, Boey ML, Wee GB et al (1997) Possible protective role of HLA-B*2706 for ankylosing spondylitis. Tissue Antigens 49:67–69 Hou TY, Chen HC, Chen CH, Chang DM, Liu FC et al (2007) Usefulness of human leucocyte antigen-B27 subtypes in predicting ankylosing spondylitis: Taiwan experience. Intern Med J 37:749–752 Ma HJ, Hu FP (2006) Diversity of human leukocyte antigen-B27 alleles in Han population of Hunan province, southern China. Tissue Antigens 68:163–166 Chou CT, Chen JM, Hsu CM, Chen SJ (2003) HLA-B27 and its subtypes in 4 Taiwanese aborigine tribes: a comparison to Han Chinese patients with ankylosing spondylitis. J Rheumatol 30:321–325 Park SH, Kim J, Kim SG, Kim SK, Chung WT et al (2009) Human leucocyte antigen-B27 subtypes in Korean patients with ankylosing spondylitis: higher B*2705 in the patient group. Int J Rheum Dis 12:34–38 Yang M, Xu M, Pan X, Hu Z, Li Q et al (2013) Epidemiological comparison of clinical manifestations according to HLA-B*27 carrier status of Chinese ankylosing spondylitis patients. Tissue Antigens 82:338–343 Wu Z, Lin Z, Wei Q, Gu J (2009) Clinical features of ankylosing spondylitis may correlate with HLA-B27 polymorphism. Rheumatol Int 29:389–392 Sun L, Wu R, Xue Q, Wang F, Lu P (2016) Risk factors of uveitis in ankylosing spondylitis: an observational study. Medicine (Baltimore) 95:e4233 Yang T, Duan Z, Wu S, Liu S, Zeng Z et al (2014) Association of HLA-B27 genetic polymorphisms with ankylosing spondylitis susceptibility worldwide: a meta-analysis. Modern Rheumatol 24:150–161 Zhang L, Liu JL, Zhang YJ, Wang H (2011) Association between HLA-B*27 polymorphisms and ankylosing spondylitis in Han populations: a meta-analysis. Clin Exp Rheumatol 29:285–292 Kim TJ, Na KS, Lee HJ, Lee B, Kim TH (2009) HLA-B27 homozygosity has no influence on clinical manifestations and functional disability in ankylosing spondylitis. Clin Exp Rheumatol 27:574–579